Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARVINAS, INC. | 96,021 | reported | 06 Mar 2026 | tx 26+238,339−74,296 |
| Syndax Pharmaceuticals Inc | 34,836 | reported | 07 Feb 2024 | tx 88+2,611,728−2,464,941 |
| Repare Therapeutics Inc. | 27,200 | reported | 17 Jun 2024 | tx 5+129,200 |
| Werewolf Therapeutics, Inc. | 27,000 | reported | 12 Jun 2025 | tx 5+92,500 |
| Eleven Biotherapeutics, Inc. | 19,350 | reported | 26 Jun 2024 | tx 5+167,724 |
| NextCure, Inc. | 14,250 | reported | 11 Jun 2020 | tx 2+36,250 |
| CRISPR Therapeutics AG | 13,000 | reported | 05 Jun 2025 | tx 1+13,000 |
| Codiak BioSciences, Inc. | 4,761 | reported | 17 Feb 2021 | tx 2+14,761 |
1 purchase reported after at least 12 months of silence — most recent on 22 Sept 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | PURCHASE | ARVINAS, INC. | 20,000 | 13.40 USD | |
| 22 Sept 2025 | PURCHASE | ARVINAS, INC. | 30,000 | 7.57 USD | first after silence |
| 25 Jun 2025 | GRANT_AWARD | ARVINAS, INC. | 16,025 | 0.00 USD | |
| 25 Jun 2025 | GRANT_AWARD | ARVINAS, INC. | 23,105 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Eleven Biotherapeutics, Inc. | 19,350 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Repare Therapeutics Inc. | 27,200 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | ARVINAS, INC. | 5,899 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | ARVINAS, INC. | 9,070 | 0.00 USD | deriv |
| 24 May 2024 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 17,000 | 0.00 USD | |
| 09 Aug 2023 | SALE | Syndax Pharmaceuticals Inc | 52,855 | 18.27 USD | |
| 09 Aug 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 52,855 | 8.77 USD | |
| 09 Aug 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 52,855 | 0.00 USD | deriv |
| 10 Jul 2023 | SALE | Syndax Pharmaceuticals Inc | 52,855 | 20.40 USD | |
| 10 Jul 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 52,855 | 8.77 USD | |
| 10 Jul 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 52,855 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | Werewolf Therapeutics, Inc. | 13,200 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | ARVINAS, INC. | 4,121 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | ARVINAS, INC. | 12,787 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Repare Therapeutics Inc. | 27,200 | 0.00 USD | deriv |
| 09 Jun 2023 | SALE | Syndax Pharmaceuticals Inc | 28,273 | 21.18 USD | |
| 09 Jun 2023 | SALE | Syndax Pharmaceuticals Inc | 24,582 | 21.18 USD | |
| 09 Jun 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 24,582 | 6.38 USD |